Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyzed C H Functionalization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105622544A details a one-step Rh-catalyzed route to N-sulfonyl-3,4-dihydro-2H-1,4-thiazine, offering streamlined manufacturing and high purity for pharmaceutical intermediates.
Discover a novel one-pot rhodium-catalyzed synthesis for indazolo[2,3-a]quinolines. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN111592549B reveals a novel Rh-catalyzed [4+1] cyclization for quinazolinone derivatives, offering streamlined synthesis and cost reduction in API manufacturing.
Patent CN115557900A details a mild Rh-catalyzed route to 3-substituted pyridazines with quaternary centers, offering high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.